分块EMR后延长监测:低危患者初始监测的安全策略
该回顾性研究纳入2018至2021年间193例接受≥20mm结肠息肉分块EMR的患者,按息肉特征分6个月或12个月监测组。6个月组复发率31.5%高于12个月组14.3%(P<.05),初始息肉管状绒毛状组织学是唯一复发相关因素。风险分层可将低危患者监测延长至12个月。
要点
- 分块EMR后6个月监测组复发率31.5%,12个月组14.3%。
- 初始息肉管状绒毛状组织学是唯一与复发相关的因素。
- 低危患者可安全将监测延长至12个月,减少不必要操作。
核心结论
- 风险分层方法可安全地将低风险患者分块EMR后的监测延长至12个月,减少不必要操作而不影响诊疗。
研究设计与样本
- 回顾性研究,纳入2018至2021年间接受≥20mm结肠息肉分块EMR的患者193例,按息肉特征分为6个月或12个月监测组。
主要发现
- 193例患者中,6个月监测组复发率为31.5%,12个月组为14.3%(P<.05)。
- 复发患者中,6个月随访组在指数结肠镜检查时管状绒毛状腺瘤更多(P<.05)。
- 初始息肉管状绒毛状组织学是唯一与复发相关的因素。
临床怎么用
- 对低风险患者(如无管状绒毛状组织学)可考虑将分块EMR后监测延长至12个月,以减少不必要的结肠镜检查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Piecemeal endoscopic mucosal resection (EMR) is the standard of care for large, nonpedunculated colon polyps but is associated with recurrence rates of 9% to 31%. Current guidelines recommend 6-month surveillance for all patients, although this may not be necessary for lower-risk cases. METHODS: We retrospectively reviewed patients who underwent piecemeal EMR of ≥20-mm colon polyps between 2018 and 2021. Patients were stratified into 6- or 12-month surveillance groups based on polyp features. Recurrence rates and associated factors were compared. RESULTS: Among 193 patients, recurrence was higher in the 6-month (31.5%) than in the 12-month group (14.3%, P < .05). Among patients with recurrence, the 6-month follow-up group had more tubulovillous adenomas (P < .05) on index colonoscopy. Tubulovillous histology in the initial polyp was the only factor associated with recurrence. CONCLUSIONS: A risk-stratified approach may safely extend surveillance to 12 months for lower-risk patients after piecemeal EMR, reducing unnecessary procedures without compromising care.
引用
- Perry NJ, Bhatte S, Triggs JR, et al. Extended surveillance after piecemeal endoscopic mucosal resection: a safe approach to initial surveillance in low-risk patients. Gastrointest Endosc. 2025. PMID: 41115477. doi:10.1016/j.gie.2025.10.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。